CG Oncology, Inc. (NASDAQ:CGON) Stock Position Lessened by Yu …

3 days ago · Yu Fan decreased its position in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 89.6% in the third quarter, according to its most recent Form 13F filing with …

CouponFollow Extension

6%
OFF

CG Oncology, Inc. (NASDAQ:CGON) Stock Position Lessened By Yu …

4 weeks from now

3 days ago · Yu Fan decreased its position in shares of CG Oncology, Inc. (NASDAQ:CGON - Free Report) by 89.6% in the third quarter, according to its most recent Form 13F filing with …

marketbeat.com

$5.06
OFF

CG Oncology, Inc. (CGON) Interactive Stock Chart - Yahoo Finance

4 weeks from now

Bullish CG Oncology Insiders Loaded Up On US$5.06m Of Stock Simply Wall St. • 3 months ago CG Oncology Reports Second Quarter 2024 Financial Results and Provides Business Updates

yahoo.com

$32.37
OFF

CG Oncology Stock Price | CGON Stock Quote, News, And History

4 weeks from now

On Friday 11/22/2024 the closing price of the CG Oncology Inc Registered Shs share was $32.37 on BTT. Compared to the opening price on Friday 11/22/2024 on BTT of $32.58, this is a drop …

businessinsider.com

FAQs about CG Oncology, Inc. (NASDAQ:CGON) Stock Position Lessened by Yu … Coupon?

How much is CG oncology worth?

The company's lead drug targets a sizable addressa... CG Oncology CGON.O notched up a valuation of $1.75 billion in its market debut on Thursday, after shares of the cancer drug developer rose 52.6% at the open on the Nasdaq. ...

Is CG oncology a good IPO?

Biotech stocks have fallen about 1% so far this year. With a lead asset in advanced Phase-III testing, CG Oncology, which debuts Thursday on the NASDAQ, is one of the year's most highly anticipated IPOs. The company's lead drug targets a sizable addressa... ...

Will CG oncology raise $100 million in a public offering?

IRVINE, Calif.-- (BUSINESS WIRE)--CG Oncology Announces Pricing of Upsized Initial Public Offering. CG Oncology, a Phase 3 biotech developing an oncolytic immunotherapy for bladder cancer, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering. ...

What does CG oncology stand for?

IRVINE, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone blad... ...

Will CG Oncology GO Public?

The firm aims to list on the Nasdaq under the symbol CGON. CG Oncology has filed to go public with an IPO on the NASDAQ. CG Oncology has received fast track designation and breakthrough designation needed to accelerate US FDA submission. ...

Who is CG oncology?

PREV. CLOSE CG Oncology, Inc. is a late-stage biopharmaceutical company. The Company focuses on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology serves medical sector in the United States. ...